Literature DB >> 6617575

Origin of insulin-receptive nerve terminals in rat median eminence.

M van Houten, D M Nance, S Gauthier, B I Posner.   

Abstract

The origin of insulin-receptive axon terminals in the rat median eminence was determined by combining surgical and chemical ablation techniques and the in vivo radioautographic approach, in which labeling of the median eminence with blood-borne [125I]insulin served as a quantifiable marker for the presence of receptive axonal elements. Whereas unilateral deafferentation of the median eminence from the ipsilateral brain produced as much as a 50% ipsilateral loss of insulin-binding sites, transection of axonal projections to median eminence from neurons located lateral to the ventromedial hypothalamic nucleus produced no detectable loss in insulin-binding capacity. Unilateral electrocoagulation of various regions of the medial basal hypothalamus indicated that insulin-receptive axon terminals arise primarily from neurons in and about the hypothalamic arcuate nucleus and from the posterior ventrolateral subdivision of the hypothalamic ventromedial nucleus. A primary site of origin from the arcuate nucleus was confirmed in rats treated neonatally with monosodium L-glutamate, which, in addition to a selective destruction of arcuate neurons, produced a profound reduction in the insulin-specific binding capacity of the median eminence. The results of this study indicate that insulin-binding axon terminals arise from a unique class of tuberoinfundibular neuron with hormone-receptive capacity. These neurons may function to mediate direct interaction of circulating insulin with central autonomical, behavioral, and neuroendocrine systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617575     DOI: 10.1210/endo-113-4-1393

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  NH2-terminal specificity and axonal localization of adrenocorticotropin binding sites in rat median eminence.

Authors:  M Van Houten; M N Khan; R J Walsh; G B Baquiran; L P Renaud; C Bourque; S Sgro; S Gauthier; M Chretien; B I Posner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Metergoline, naloxone, and sodium valproate did not modify arginine vasopressin response to insulin-induced hypoglycemia in man.

Authors:  P Chiodera; A Gnudi; R Volpi; L d'Amato; C Marchesi; G Pioli; P Muzzetto; A Castelli; L Bianconi; R Minelli
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

3.  Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men.

Authors:  V Coiro; L Capretti; G Speroni; A Castelli; L Bianconi; U Cavazzini; A Marcato; R Volpi; P Chiodera
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

4.  The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia.

Authors:  Lorna Moll; Markus Schubert
Journal:  Curr Gerontol Geriatr Res       Date:  2012-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.